Relapsing Multiple Sclerosis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-01-14
Clinical Trial Update: Ofatumumab in Portuguese Multiple Sclerosis Patients - an Observational Study
An observational study in Portugal is evaluating ofatumumab for relapsing multiple sclerosis and is currently recruiting.